Mon, Dec 29, 2014, 2:54 AM EST - U.S. Markets open in 6 hrs 36 mins

Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • fizrwinnr11 fizrwinnr11 Jan 1, 2013 12:07 PM Flag

    Pfizer portfolio update

    12/31/10 - 262,215 - ($17.51) Year-end 2010 close
    12/31/11 - 481,195 - ($21.64) Year-end 2011 close

    01/03 - 488,645 - ($21.97) RSI 69.5
    01/12 - 501,920 - ($21.99) RSI 65.8
    02/01 - 488,525 - ($21.31) Ex-dividend 22 cents, RSI 47.1
    02/06 - 471,285 - ($20.95) 2012 valuation low, RSI 43.4
    03/30 - 555,110 - ($22.65) RSI 72.9, an interim 2012 high
    04/13 - 527,300 - ($21.85) 9 straight losing sessions, RSI 45.4
    04/27 - 577,965 - ($23.08) RSI 70.0
    05/04 - 555,335 - ($22.38) RSI 47.7
    05/09 - 559,605 - ($22.45) Ex-dividend 22 cents, RSI 56.3
    05/10 - 574,430 - ($22.83) Tofacitinib recommended, RSI 64.0
    06/05 - 524,015 - ($21.60) RSI 33.6, lowest in ten months
    07/02 - 604,505 - ($23.00) RSI 65.6
    07/11 - 576,620 - ($22.34) RSI 45.5
    07/19 - 633,095 - ($23.80) RSI 72.2
    07/25 - 616,455 - ($23.33) RSI 58.6
    07/27 - 639,325 - ($23.83) RSI 67.0
    08/01 - 638,820 - ($23.94) Ex-dividend 22 cents, RSI 70.1
    08/03 - 650,580 - ($24.28) RSI 73.9
    08/07 - 641.145 - ($23.74) Bapi fails, RSI 59.0
    08/15 - 652,925 - ($24.04) RSI 62.1
    08/21 - 644,640 - ($23.69) RSI 52.1
    09/13 - 672,300 - ($24.25) RSI 59.6
    09/14 - 658,780 - ($23.80) RSI 47.8
    10/18 - 710,540 - ($26.04) RSI 76.2, Highest since Q3-06
    11/06 - 680,760 - ($24.78) RSI 43.3, Election Day
    11/07 - 654,695 - ($24.17) Ex-dividend 22 cents, RSI 38.1)
    11/15 - 632,975 - ($23.66) RSI 30.0, Lowest in 15 months
    12/18 - 724,870 - ($25.64) All-time valuation high, 9% dividend hike announced, RSI 63.0
    12/21 - 699,815 - ($25.08) RSI 49.7
    12/28 - 690,590 - ($24.89) RSI 45.6
    12/31 - 701,950 - ($25.08) RSI 49.7



    Up 45.4%. 2012 Portfolio gain based on $220,755 valuation increase less $3,,000 interest
    Up 38.7%. 2012 Portfolio gain based on return on invested capital
    Up 20.0%. 2012 Pfizer stock price gain including four 22-cent dividends

    Up 13.4%. S & P 500 gain to date (1,258 to 1,426)



    Note: This portfolio had a steady cost basis of $100,000 from 11/17/04 inception through 6/2/08. From that date through mid-March of 2009, additional funds were invested until the cost basis reached $296,110. The basis has remained steady again since that time.

    Note: This portfolio was up by as much as 96K pre-crash on 6/1/07 with the stock closing at $27.68 that day. It was also down as much as 333K on 3/2/09 when the stock closed at $11.66. Gains of 429K from inception were seen on 12/18/12 with the stock at $25.64. Current gains are 406K.

    Note: Over time, the leverage factor at these portfolio levels is about 1.9, the lowest since inception. It was designed at the end of 2011 to go up by about 59K per Pfizer point up to $25 on the stock and then 53K a point thereafter. .

    Note: Average annualized gains from inception stands at 10.9% and considers all additional funds needed to margin the naked puts.

    Note: The 2012 increase in valuation of 221K was almost the same as the 2011 increase of 219K.

    Sentiment: Buy

 
PFE
31.65+0.23(+0.73%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.